Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Clinical Trial Using Topical Sirolimus for the Treatment of Pachyonychia Congenita

NCT02152007 is registered in ClinicalTrials.gov with TransDerm, Inc. as lead sponsor.

NCT NCT02152007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02152007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Clinical Trial Using Topical Sirolimus for the Treatment of Pachyonychia Congenita
Lead sponsor
TransDerm, Inc.
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2014
Completion date
November 30, 2015
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pachyonychia congenita